BioMarin Pharmaceutical Inc
BMRN· Nasdaq
Released Aug 1, 2019, after the close
10-Q filed Aug 2, 2019, 33 days after period end · 0001048477-19-000007
| Metric | Q2 2019 | Q2 2018 | Q2 2017 | Q2 2016 |
|---|---|---|---|---|
| Revenue | $387.76M | $372.85M | $317.45M | $300.13M |
| Net Income | -$37.44M | -$16.79M | -$36.83M | -$419.01M |
| EPS Diluted |
BioMarin Pharmaceutical Inc · CIK 1048477 · Engraved from SEC EDGAR
| -$0.21 |
| -$0.09 |
| -$0.21 |
| -$2.58 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.